《大行報告》花旗:領展(00823.HK)年度業績略低預期 利息支出較預期高
花旗發表研究報告指,領展(00823.HK)2023財年業績略為低於預期,主要是由於高於預期的利息支出;全年每基金分派(DPU)2.7431元,按年跌10.3%;股息收益率為5.9%。雖然整體DPU略低於該行預測,但其經營業績依然強勁。該行認為,2023財年已考慮到近期供股的所有攤薄影響,這應會推動集團從2024財年開始實現穩定的DPU增長。
該行提到,集團收入按年增長5.4%至122.34億元。租金收入增長是由於香港零售物業租金上調7.1%、停車場收入增加以及新收購的內地/海外資產的貢獻,但被內地投資組合的負增長略微抵銷。該行予集團「買入」評級,目標價為59.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.